Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: Conditioned place preference to morphine induces CREB phosphorylation

Neuropsychopharmacology

Volumn 35, Issue 4, 2010, Pages 955-966

  Morón, José A ^a,b   Gullapalli, Srinivas ^a   Taylor, Chirisse ^a   Gupta, Achla ^a   Gomes, Ivone ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Addiction; Drug reward; Morphine; Opioid receptors; Sensitization

Indexed keywords

AMPA RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DELTA OPIATE RECEPTOR; GLUTAMATE RECEPTOR 1; MORPHINE; NALTRIBEN; PHOSPHOPROTEIN PHOSPHATASE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONDITIONING; DRUG ANTAGONISM; DRUG SENSITIZATION; HIPPOCAMPUS; MALE; MEMORY CONSOLIDATION; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REWARD; SINGLE DRUG DOSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 76749086074     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.199     Document Type: Article

References (46)

1. Abdelhamid E, Sultana M, Portoghese P, Takemori A (1991). Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258: 299-303.
2. Bardo MT, Rowlett JK, Harris MJ (1995). Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19: 39-51.
3. Carlezon Jr WA, Duman RS, Nestler EJ (2005). The many faces of CREB. Trends Neurosci 28: 436-445.
4. Corrigall WA, Linseman MA (1988). Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav 30: 787-789.
5. Daniels D, Lenard N, Etienne C, Law P, Roerig S, Portoghese P (2005). Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci USA 102: 19208-19213.
6. Everitt BJ, Wolf ME (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312-3320.
7. Ferbinteanu J, McDonald RJ (2001). Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus 11: 187-200.
8. Fuchs RA, Evans KA, Ledford CC, Parker MP, Case JM, Mehta RH et al (2005). The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharma-cology 30: 296-309.
9. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K (1996). Functional coupling of the delta, mu, and kappa-opioid receptors to mitogen-activated protein kinase and arachido-nate release in Chinese hamster ovary cells. J Neurochem 67: 1309-1316.
10. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004). A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 101: 5135-5139.
11. He L, Lee NM (1998). Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther 285: 1181-1186.
12. Heidbreder C, Goldberg SR, Shippenberg TS (1993). Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. Eur J Pharmacol 243: 123-127.
13. Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703.
14. Kalivas PW, Stewart J (1991). Dopamine transmission in the initiation and expression of drug-and stress-induced sensitiza-tion of motor activity. Brain Res Brain Res Rev 16: 223-244.
15. Koob GF, Sanna PP, Bloom FE (1998). Neuroscience of addiction. Neuron 21: 467-476.
16. Law PY, Wong YH, Loh HH (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389-430.
17. McGaugh JL (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27: 1-28.
18. Milekic MH, Brown SD, Castellini C, Alberini CM (2006). Persistent disruption of an established morphine conditioned place preference. J Neurosci 26: 3010-3020.
19. Morris RG, Moser EI, Riedel G, Martin SJ, Sandin J, Day M et al (2003). Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc London B Biol Sci 358: 773-786.
20. Mueller D, Perdikaris D, Stewart J (2002). Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 136: 389-397.
21. Narita M, Funada M, Suzuki T (2001). Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89: 1-15.
22. Nestler EJ (1997). Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7: 713-719.
23. Nestler EJ (2001). Molecular neurobiology of addiction. Am J Addict 10: 201-217.
24. O'Brien CP, Childress AR, McLellan AT, Ehrman R (1992). Classical conditioning in drug-dependent humans. Ann NY Acad Sci 654: 400-415.
25. Olson VG, Zabetian CP, Bolanos CA, Edwards S, Barrot M, Eisch AJ et al (2005). Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25: 5553-5562.
26. Pentney RJ, Gratton A (1991). Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45: 95-102.
27. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, Comb MJ (1998). mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273: 23534-23541.
28. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI (1992). Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263: 147-152.
29. Portoghese P, Sultana M, Nagase H, Takemori A (1992). A highly selective delta-1-opioid receptor antagonist: 7-benzylidenenal-trexone. Eur J Pharmacol 218: 195-196.
30. Pu L, Bao GB, Xu NJ, Ma L, Pei G (2002). Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 22: 1914-1921.
31. 2+/calmodulin kinase IV-deficient mice. J Neurosci 20: RC107.
32. Robbins TW, Everitt BJ (2002). Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem 78: 625-636.
33. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996). Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16: 1179-1188.
34. Sanchez-Blazquez P, Garcia-espana A, Garzon J (1997). Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors. J Pharmacol Exp Ther 280: 1423-1431.
35. Shippenberg TS, Chefer VI, Thompson AC (2009). Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry 65: 169-174.
36. Shippenberg TS, Heidbreder C (1995). The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 280: 55-61.
37. Shippenberg TS, Heidbreder C, Lefevour A (1996). Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299: 33-39. (Pubitemid 26103434)
38. Shippenberg TS, Lefevour A, Thompson AC (1998). Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of kappa-opioid receptor agonist U69593. Eur J Pharmacol 354: 27-34.
39. Sofouglu M, Portoghese P, Takemori A (1991). Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257: 676-680.
40. Spanagel R, Herz A, Shippenberg TS (1990). The effects of opioid peptides on dopamine release in the nucleus accum-bens: an in vivo microdialysis study. J Neurochem 55: 1734-1740.
41. Walters CL, Blendy JA (2001). Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21: 9438-9444.
42. Wolf ME (2002). Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2: 146-157.
43. Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME (1998). Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18: 1946-1955.
44. Xu NJ, Bao L, Fan HP, Bao GB, Pu L, Lu YJ et al (2003). Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J Neurosci 23: 4775-4784.
45. Zhou LF, Zhu YP (2006). Changes of CREB in rat hippocampus, prefrontal cortex and nucleus accumbens during three phases of morphine induced conditioned place preference in rats. J Zhejiang Univ Sci B 7: 107-113.
46. Zhu Y, King M, Schuller A, Nitsche J, Reidl M, Elde R et al (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243-252.